These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25553365)

  • 1. Neuroprotective agents and modulation of temporal lobe epilepsy.
    Fernandes MJ; Carneiro JE; Amorim RP; Araujo MG; Nehlig A
    Front Biosci (Elite Ed); 2015 Jan; 7(1):79-93. PubMed ID: 25553365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.
    Godoy LD; Liberato JL; Celani MVB; Gobbo-Neto L; Lopes NP; Dos Santos WF
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28841161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-epileptogenic and Anti-convulsive Effects of Fingolimod in Experimental Temporal Lobe Epilepsy.
    Pitsch J; Kuehn JC; Gnatkovsky V; Müller JA; van Loo KMJ; de Curtis M; Vatter H; Schoch S; Elger CE; Becker AJ
    Mol Neurobiol; 2019 Mar; 56(3):1825-1840. PubMed ID: 29934763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats.
    Ge YX; Lin YY; Bi QQ; Chen YJ
    Curr Neurovasc Res; 2020; 17(4):354-360. PubMed ID: 32407277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in neuroprotective strategies for preventing epilepsy.
    Acharya MM; Hattiangady B; Shetty AK
    Prog Neurobiol; 2008 Apr; 84(4):363-404. PubMed ID: 18207302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem.
    Sloviter RS; Bumanglag AV
    Neuropharmacology; 2013 Jun; 69():3-15. PubMed ID: 22342985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
    Glien M; Brandt C; Potschka H; Löscher W
    Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and anticonvulsant effects of sinomenine in kainate rat model of temporal lobe epilepsy: Involvement of oxidative stress, inflammation and pyroptosis.
    Ramazi S; Fahanik-Babaei J; Mohamadi-Zarch SM; Tashakori-Miyanroudi M; Nourabadi D; Nazari-Serenjeh M; Roghani M; Baluchnejadmojarad T
    J Chem Neuroanat; 2020 Oct; 108():101800. PubMed ID: 32430101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-epileptogenic effect of NRP2945 in the pilocarpine model of temporal lobe epilepsy.
    Lovisari F; Guarino A; Soukupova M; Falcicchia C; Ingusci S; Marino P; Thomas M; Sieg F; Simonato M
    Eur J Pharmacol; 2021 Jun; 901():174068. PubMed ID: 33798600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy.
    Brandt C; Potschka H; Löscher W; Ebert U
    Neuroscience; 2003; 118(3):727-40. PubMed ID: 12710980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy.
    Liberato JL; Godoy LD; Cunha AOS; Mortari MR; de Oliveira Beleboni R; Fontana ACK; Lopes NP; Dos Santos WF
    Toxins (Basel); 2018 Nov; 10(12):. PubMed ID: 30469496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroprotection in epilepsy].
    Chepurnov SA; Suleĭmanova EM; Guliaev MV; Abbasova KR; Pirogov IuA; Chepurnova NE
    Usp Fiziol Nauk; 2012; 43(2):55-71. PubMed ID: 22690591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models.
    Pitkänen A
    Epilepsy Res; 2002 Jun; 50(1-2):141-60. PubMed ID: 12151125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
    Klein S; Bankstahl M; Löscher W
    Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interictal psychosis of epilepsy].
    de Toffol B; Adachi N; Kanemoto K; El-Hage W; Hingray C
    Encephale; 2020 Dec; 46(6):482-492. PubMed ID: 32594995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy.
    Tchekalarova JD; Ivanova NM; Pechlivanova DM; Atanasova D; Lazarov N; Kortenska L; Mitreva R; Lozanov V; Stoynev A
    Pharmacol Biochem Behav; 2014 Dec; 127():27-36. PubMed ID: 25456349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.
    Palleria C; Coppola A; Citraro R; Del Gaudio L; Striano S; De Sarro G; Russo E
    Expert Opin Pharmacother; 2015; 16(15):2355-71. PubMed ID: 26328621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Lacosamide Treatment on Epileptogenesis, Neuronal Damage and Behavioral Comorbidities in a Rat Model of Temporal Lobe Epilepsy.
    Shishmanova-Doseva M; Atanasova D; Uzunova Y; Yoanidu L; Peychev L; Marinov P; Tchekalarova J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome.
    Spooner CG; Berkovic SF; Mitchell LA; Wrennall JA; Harvey AS
    Neurology; 2006 Dec; 67(12):2147-53. PubMed ID: 17082466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.